BVE Invests in Psilera, Inc, a Next-Generation Psychedelics Biotech Focused on Hard-to-Treat Neurological Disorders
Tampa, Fla., June 28, 2024 – Bonaventure Equity, LLC (BVE), a leading venture capital firm specializing in life sciences discoveries inspired by cannabinoids and psychedelic compounds, is thrilled to announce its latest investment in Psilera, Inc. (Psilera). This Tampa-based biotech company is at the forefront of developing non-psychoactive, psychedelic-inspired compounds called neuroplastogens for hard-to-treat neurological disorders. […]